Therefore, I started BPC 157 at 500 mcg nightly and my recovery was remarkable for the level of injury I incurred
The next step involves a review period, during which the FDA will propose rules and the public will be able to comment
Thats a major step forward for patients with chronic gut conditions. What Research Says About KPV Clinical research supports KPVs potential as a safe, targeted therapy for inflammatory bowel disease
According to a recent study, a subset of patients who were administered leuco-methylthioninium bis-hydromethanesulfonate (LMTM), a modified version of MB, as the sole treatment, exhibited a significant reduction in the extent of illness advancement compared to the control group [23]
Expected appearance: Clear, colorless solution with no particulates
For many of the spots the patient receives injections in according to the injection paradigm, they may not have much headache or pain at baseline